Abiopharma

Clinical trial NCT04396574: enrollment: 566 → 558 participants.

Clinical trial NCT07366658: status: NOT_YET_RECRUITING → RECRUITING.

Clinical trial NCT06280209 updates: 1. status: RECRUITING → ACTIVE_NOT_RECRUITING 2. completion date: 2026-09-30 → 2027-04-14 3. primary completion date: 2026-09-30 → 2027-04-14 4. enrollment type: ESTIMATED → ACTUAL

Clinical trial NCT07100925 updates: 1. status: NOT_YET_RECRUITING → WITHDRAWN 2. enrollment: 20 → 0 participants 3. enrollment type: ESTIMATED → ACTUAL

Clinical trial NCT05144854: primary completion date: 2026-05-01 → 2025-10-20.

Clinical trial NCT07174063 updates: 1. completion date: 2027-06-18 → 2027-01-29 2. primary completion date: 2027-06-18 → 2027-01-29

Clinical trial NCT06526793 updates: 1. completion date: 2029-06-14 → 2032-10-21 2. primary completion date: 2027-03-10 → 2027-11-24 3. enrollment: 240 → 270 participants

Clinical trial NCT06721013 updates: 1. completion date: 2027-02-01 → 2029-05-01 2. primary completion date: 2026-12-01 → 2028-05-01 3. enrollment: 58 → 68 participants

Clinical trial NCT06468878 updates: 1. status: RECRUITING → COMPLETED 2. completion date: 2025-05-01 → 2025-12-01 3. primary completion date: 2025-05-01 → 2025-12-01 4. enrollment: 44 → 60 participants 5. enrollment type: ESTIMATED → ACTUAL

Clinical trial NCT06182241 updates: 1. status: NOT_YET_RECRUITING → RECRUITING 2. start date: 2025-10-15 → 2025-11-17 3. completion date: 2026-05-31 → 2026-06-30 4. primary completion date: 2026-05-31 → 2026-06-30